GRIFOLS | GRF - Passivo Circulante





Passivo Circulante Alterar Data
Alcon AG USD 3B 45M 2026-03
Almirall EUR 350.64M 52.12M 2025-12
Amadeus IT EUR 3.03B 4.4M 2026-03
Amarin USD 179.64M 14.82M 2026-03
argenx SE USD 1.32B 278.28M 2025-12
AstraZeneca USD 32.57B 1.95B 2026-03
Bayer EUR 33.46B 875M 2026-03
Cie Automotive EUR 1.92B 8.97M 2025-12
Demant DKK 7.42B 1.63B 2025-12
Ence Energia y Celulosa EUR 435.03M 5.93M 2025-12
Essilor EUR 12.15B 766M 2025-12
Ferrovial EUR 6.46B 486M 2025-12
Fresenius EUR 8.38B 1.18B 2025-12
Fresenius Medical Care EUR 6.73B 484.42M 2026-03
Genmab DKK 1.43B 686M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
GRIFOLS EUR 2.12B 105M 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Inditex EUR 12.47B 2.29B 2026-03
Lakefront Biotherapeutics EUR 100.42M 52.44M 2026-03
Merck EUR 9.35B 307M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Philips EUR 7.43B 78M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
Smith & Nephew USD 1.54B 236M 2025-12
UCB EUR 4.4B 470M 2025-12
Viscofan EUR 437.49M 43.64M 2026-03